Form 4: Maravai LifeSciences CEO William E. Martin, III, Reports Tax-Related Stock Disposal

William E. Martin, III, CEO of Maravai LifeSciences Holdings, Inc., disposed of 50,843 shares of Class A Common Stock on October 15, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• On October 15, 2024, William E. Martin, III, the Chief Executive Officer of Maravai LifeSciences Holdings, Inc., disposed of 50,843 shares of Class A Common Stock.
• The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock unit awards.
• The shares were disposed of at a price of $8.29 per share.
• Following the transaction, Martin directly owns 989,430 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to stock transactions by a company executive for tax purposes. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for stock disposals by executives.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a routine disposal of shares to cover tax obligations.

Key Dates